Sun Chong, Li Yan, Ma Shuli. Clinical Analysis and Literature Review of Levofloxacin in the Treatment of Neonatal Burkholderia Cepacia Infection. [J]. 26(11):31-34(2020)
DOI:
Sun Chong, Li Yan, Ma Shuli. Clinical Analysis and Literature Review of Levofloxacin in the Treatment of Neonatal Burkholderia Cepacia Infection. [J]. 26(11):31-34(2020) DOI: 10.13407/j.cnki.jpp.1672-108X.2020.11.010.
Clinical Analysis and Literature Review of Levofloxacin in the Treatment of Neonatal Burkholderia Cepacia Infection
Objective: To probe into the role of clinical pharmacists in anti-infective treatment of neonatal Burkholderia cepacia infection. Methods: Retrospective analysis was performed on clinical pharmacists’ participation of levofloxacin in the treatment of neonatal Burkholderia cepacia infection. Results: Clinical pharmacists assessed the risks and benefits of levofloxacin for neonatal infection
and participated into the adjustment of anti-infective regimens. After comprehensive treatment
the child’s respiration was better than before
and the body temperature returned to the normal state. Conclusion: After fully assessing the risks and benefits
fluoroquinolones can be used to treat life-threatening or difficult-to-treat children with infections
which will help to reduce the mortality of pediatrics with severe Burkholderia cepacia infection.